Herceptin
Quick Facts
Generic Name
Trastuzumab
Date Approved
9/25/1998
Manufacturer
Genentech
Status
8/31/05 FDA warning
Approved Uses
Breast Cancer
Serious Side Effects
Heart problems
Increased cardiotoxicity
Death
Related Topics
Breast Cancer
Defective Drugs
Diseases
CLICK HERE TO DOWNLOAD OUR HERCEPTIN INFORMATION PACKAGE
Herceptin Side Effects May Result In Heart Failure Lawsuits
Herceptin | Lawsuits, Lawyers | Side Effects: Heart Failure, Heart Problems, Cardiotoxicity, Damage To Heart Muscle
On August 31, 2005, the FDA issued a warning about the potential heart problems associated with use of the breast cancer drug Herceptin (Generic: Trastuzumab). A recent study showed that Herceptin, manufactured by Genentech Inc., significantly increases the risk of heart problems. The study confirmed a significant increase in cardio toxicity in patients who were randomized to the Herceptin-containing (group) as compared to patients who received chemotherapy alone.
The label for Herceptin already includes information about possible heart failure and heart ventricle problems. The randomized, late-stage study of 2,043 breast cancer patients found a higher incidence of damage to the heart muscle, known as cardiac toxicity, in the 1,019 patients taking Herceptin. Such damage can lead to heart failure or even death. A statistically significant increase in the 3-year cumulative incidence of congestive heart failure and cardiac death was observed in patients who received the Herceptin-containing regimen (4.1 percent) compared with control (0.8 percent), a letter written by the manufacturer stated.
Genentech sent a letter to doctors in August 2005. The U.S. Food and Drug Administration published the letter on its website at: www.fda.gov/medwatch/safety/2005/HerceptinDDL_0805.FINAL.pdf
Legal Help For Victims Affected By Herceptin
If you or a loved one took Herceptin and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-LAW-INFO (1-800-529-4636).










